Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alzamend Neuro Inc

Current price
0.45 USD -0.11 USD (-19.83%)
Last closed 0.57 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 168 814 USD
Yield for 12 month -32.73 %
21.11.2021 - 28.11.2021

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Address: 3480 Peachtree Road NE, Atlanta, GA, United States, 30326

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

21 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-23 066 USD

Last Year

Current Quarter

-12 685 USD

Last Quarter

-12 685 USD

Key Figures ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 349 212 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -166.84 %
PEG Ratio
Return On Equity TTM -1196.26 %
Wall Street Target Price 21 USD
Revenue TTM
Book Value -0.63 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.76 USD
Diluted Eps TTM -1.76 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALZN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 31.10.2023
Dividend Date

Stock Valuation ALZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.4497
Price Book MRQ 7.2255

Financials ALZN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALZN

For 52 weeks

0.44 USD 10.65 USD
50 Day MA 0.68 USD
Shares Short Prior Month 82 120
200 Day MA 1.5 USD
Short Ratio 0.84
Shares Short 57 364
Short Percent 1.62 %

Dynamics of changes in the value of assets




212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds



13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics



2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics